Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:30 AM ET 8-K
Partnership Nocera, Inc. NCRA

Nocera Partnership with E-Pro Display Co., Ltd.

Nocera entered into a Strategic Partnership and Joint Distribution Agreement with E-PRO DISPLAY CO., LTD. to act as a worldwide distributor for pre-owned iPhone 17 Pro handsets. While the underlying program involves an allocation of 600,000 handsets valued at $520.5 million, the agreement is a framework with no minimum purchase commitments or guaranteed revenue for Nocera.

Counterparty
E-PRO DISPLAY CO., LTD.
Term
12 months
8:26 AM ET 8-K
Capital Raise Moleculin Biotech, Inc. MBRX

Moleculin Biotech Capital Raise

Moleculin Biotech raised $0.48 million in gross proceeds through the issuance of 888,400 shares under its at-the-market (ATM) offering program in September 2026. The issuance triggered an anti-dilution provision in the company's Series I Warrants, reducing their exercise price from $0.75 to $0.51 per share.

Counterparty
Roth Capital Partners, LLC
8:25 AM ET 8-K
M&A Deal Rain Enhancement Technologies Holdco, Inc. RAIN

Rain Enhancement Technologies Holdco M&A Deal with Tensor Networks, Inc.

Rain Enhancement Technologies Holdco, Inc. (RAIN) has entered into a binding letter of intent to acquire Tensor Networks, Inc., a developer of predictive AI infrastructure security technology. The all-stock transaction will result in Tensor Networks becoming a wholly owned subsidiary of RAIN, with Tensor equity holders expected to own approximately 90% of the combined company. The deal, expected to close in Q1 2027, transforms RAIN into a multi-technology holding company.

Counterparty
Tensor Networks, Inc.
8:16 AM ET 8-K
Leadership Change Edgewell Personal Care Co EPC

Edgewell Personal Care Leadership Change

Edgewell Personal Care Company appointed LaTanya Langley as Chief Administrative and Legal Officer and Corporate Secretary, effective October 1, 2026. Ms. Langley, who previously served as Chief People Officer, will transition into the new role with no changes to her existing compensation.

8:16 AM ET 8-K
Divestiture Greenpro Capital Corp. GRNQ

Greenpro Capital Divestiture to Ms. Chen Yanhong

Greenpro Capital Corp. entered into a share sale agreement to sell its entire equity interest in six subsidiaries, collectively known as the F&A Entities, to Ms. Chen Yanhong for approximately $0.45 million in cash. The F&A Entities provide corporate advisory and company-secretarial services in Hong Kong and China. The company intends to use the proceeds for general corporate purposes and working capital.

Counterparty
Ms. Chen Yanhong
8:15 AM ET 8-K
Leadership Change Corcept Therapeutics Inc CORT

Corcept Therapeutics Leadership Change

Sean Maduck, President of Corcept Endocrinology, is resigning effective October 1, 2026, and will be succeeded by Justin Gunn. Maduck will transition to a senior commercial advisor role under a consulting agreement paying $57,000 per month through September 2027.

Counterparty
Sean Maduck
Term
1 year
8:13 AM ET 8-K
Leadership Change MeiraGTx Holdings plc MGTX

MeiraGTx Holdings Leadership Change

MeiraGTx Holdings plc appointed Alan M. Sebulsky to its Board of Directors as a Class I director, effective September 23, 2026. Mr. Sebulsky, a veteran healthcare portfolio manager with over 40 years of experience, will also serve on the company's Science and Technology Committee.

Counterparty
Alan M. Sebulsky
8:09 AM ET Form 4
Insider Selling Robinhood Markets, Inc. HOOD

Robinhood Markets CEO Vladimir Tenev Sells $32.5M of Stock

Vladimir Tenev, CEO, sold 259,166 shares of Robinhood Markets, Inc. at $125.55 to $126.15 a share (average $125.58) in 2 transactions, worth $32.5M in total on Sep 21, 2026. Shares held after the trade: 0 (-100.0%).

Value
$32.5M
Shares
259,166
Average price
$125.58
Role
CEO
Holding change
-100.0%
Trade date
Sep 21, 2026
8:07 AM ET 8-K
Leadership Change IIOT-OXYS, Inc. ITOX

IIOT-OXYS Leadership Change

IIOT-OXYS, Inc. appointed Vidhyadhar Mitta to its Board of Directors, effective September 21, 2026. Mr. Mitta previously served as a director for the company and has a history of financial involvement, including a 2025 debt exchange agreement where he converted $216,156 of debt into Series E Preferred Stock.

Counterparty
Vidhyadhar Mitta
8:06 AM ET 8-K
Investor Presentation Astrana Health, Inc. ASTH

Astrana Health Investor Presentation

Astrana Health, Inc. has updated its corporate investor presentation for use in upcoming conferences and meetings. The presentation includes strategic highlights and forward-looking information regarding the company's business operations and financial objectives.

8:04 AM ET 8-K
Loan & Debt Beyond Meat, Inc. BYND

Beyond Meat $15M Debt Financing

Beyond Meat entered into privately negotiated exchange agreements to retire $15.0 million in principal of its 0% Convertible Senior Notes due 2027. The company is exchanging the debt at 96% of its face value for shares of common stock, with an initial issuance of 1,097,444 shares and a potential 'true up' issuance of up to 848,265 additional shares based on a three-day VWAP calculation.

Value
$15M
8:04 AM ET 8-K
Investor Presentation Knife River Corp KNF

Knife River Investor Presentation

Knife River Corporation filed a formal investor presentation deck (Exhibit 99.1) for its September 2026 conference activities. The presentation outlines the company's long-term investment thesis, market dynamics, and strategic 'EDGE' initiatives focused on margin improvement and vertical integration.

8:01 AM ET 8-K
Other 8-K Filing Adagio Medical Holdings, Inc. ADGM

Adagio Medical Holdings Other 8-K Filing

Adagio Medical Holdings has initiated a formal process to explore strategic alternatives, including a potential merger or sale, to maximize shareholder value. In connection with this review, the company is reducing its workforce by 58% (25 of 43 employees) and expects to incur $1.3 million in cash expenditures for severance and related costs. Additionally, the company is lowering the conversion price for its 13% Senior Secured Convertible Notes through October 31, 2026, to facilitate potential debt conversions.

8:01 AM ET 8-K
Investor Presentation Mcdonalds Corp MCD

Mcdonalds Investor Presentation

McDonald's Corporation announced its new 'McDonald’s > NEXT' strategy, detailing long-term growth and productivity targets through 2030. The company aims to gain 1.5 percentage points of market share in chicken and beverages, expand operating margins to the low-to-mid 50% range, and achieve 250 basis points of restaurant-level efficiency gains.

8:01 AM ET 8-K
Nasdaq/NYSE Compliance Notice Lakeshore Acquisition III Corp. LCCC

Lakeshore Acquisition III Nasdaq/NYSE Compliance Notice

Lakeshore Acquisition III Corp. received approval from Nasdaq to transfer the listing of its units, ordinary shares, and rights from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer is effective at the opening of business on September 24, 2026, and the securities will continue to trade under their existing symbols (LCCCU, LCCC, and LCCCR).

Counterparty
Nasdaq
8:00 AM ET 8-K
Leadership Change Valion Bio, Inc. VBIO

Valion Bio Leadership Change

Valion Bio, Inc. appointed Dean Zikria as Interim Chief Executive Officer, effective September 22, 2026, succeeding Sheryle Bolton who stepped down from the Board. Mr. Zikria, an existing director, will receive a monthly consulting fee of $23,333 and up to 100,000 restricted stock units as part of his interim leadership agreement.

8:00 AM ET 8-K
Shareholder Meeting Saratoga Investment Corp. SAR

Saratoga Investment Shareholder Meeting

Saratoga Investment Corp. held its 2026 Annual Meeting of Stockholders on September 22, 2026. Shareholders elected G. Cabell Williams and Henri J. Steenkamp to the board of directors and ratified the selection of Ernst & Young LLP as the company's independent accounting firm for the fiscal year ending February 28, 2026.

7:46 AM ET 8-K
Investor Presentation Lantern Pharma Inc. LTRN

Lantern Pharma Investor Presentation

Lantern Pharma is hosting a live webinar and investor presentation to discuss the growth plan, development roadmap, and economics of its wholly owned subsidiary, Open-Medicine AI. The session will include a live demonstration of the multi-agentic AI platform's capabilities and an overview of the subscription and enterprise licensing model.

Earnings call
Sep 23, 2026, 12:30 PM ET
7:36 AM ET 8-K
Other 8-K Filing Beneficient BENF

Beneficient Other 8-K Filing

Beneficient announced a comprehensive strategy to eliminate approximately $130 million in fraudulent debt asserted by HCLP Nominees and $850 million in preferred equity interests held by former CEO Brad Heppner following his federal fraud conviction. The company is seeking a consensual resolution to convert Heppner's massive equity stake into just 162,132 Class A shares and terminate all remaining agreements to simplify its capital structure. If a resolution is not reached before Heppner's October 2026 sentencing, the company intends to pursue litigation to void the obligations and interests.

Counterparty
Brad Heppner
7:31 AM ET 8-K
Nasdaq/NYSE Compliance Notice Cytosorbents Corp CTSO

Cytosorbents Nasdaq/NYSE Compliance Notice

CytoSorbents has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its stock closed at or above that level for 10 consecutive trading sessions. However, the company remains non-compliant with the $35 million Minimum Market Value of Listed Securities (MVLS) requirement and has until December 28, 2026, to resolve this deficiency.

Counterparty
Nasdaq
Term
until Dec 28, 2026
7:30 AM ET 8-K
Financial Results Cracker Barrel Old Country Store, Inc CBRL

Cracker Barrel Old Country Store Financial Results

Cracker Barrel reported Q4 fiscal 2026 total revenue of $849.3 million and GAAP net income of $12.2 million, reflecting a 2.2% revenue decrease year-over-year. During the quarter, the company reduced total debt to $337.2 million following a $150 million note repayment and a $77 million sale-leaseback transaction involving 26 store locations.

Term
Q4 2026
Earnings call
Sep 23, 2026, 8:15 AM ET

“I’m honored to lead such a differentiated and iconic brand. The Company is focused on the right areas and has a strong plan, as demonstrated by the continued improvements in the underlying traffic trend, key guest metrics, and EBITDA results. I am excited about the opportunity ahead and confident that our strategic priorities around food, experience, and people will sustain this momentum and drive long-term value creation.”

David Deno, President and Chief Executive Officer
7:30 AM ET 8-K
Cybersecurity Incident Astrana Health, Inc. ASTH

Astrana Health Cybersecurity Incident

Astrana Health disclosed a material cybersecurity incident involving social engineering and unauthorized access to its systems by threat actors impersonating company personnel. The company determined the incident is material as of September 22, 2026, due to the potential compromise of sensitive patient, employee, and provider data. Remedial actions including credential resets and system restorations have been implemented while a forensic investigation remains ongoing.

7:30 AM ET 8-K
Business Update Anteris Technologies Global Corp. AVR

Anteris Technologies Global Business Update

Anteris Technologies Global Corp. entered into an amendment to its existing Supply & Quality Agreement with Harvey Industries Group Pty Ltd. The amendment extends the contract term until December 31, 2026, or until a new replacement agreement is executed, ensuring continued operational supply for the company's subsidiary.

Counterparty
Harvey Industries Group Pty Ltd
Term
through Dec 2026
7:15 AM ET 8-K
Product Launch SharonAI Holdings Inc. SHAZ

SharonAI Holdings Product Launch

SharonAI Holdings announced a collaboration with VAST Data to launch DataEnclave, a confidential AI capability integrated into Sharon AI's AI Factory platform across Australia and Asia-Pacific. The service provides a hardware-isolated secure runtime for running advanced AI models onshore, allowing regulated organizations like banks and government agencies to process sensitive data without it leaving their controlled infrastructure.

Counterparty
VAST Data

“Our customers across Australia and Asia-Pacific need to run AI at full speed without compromising on data sovereignty, and increasingly they also want access to frontier models that were previously only available offshore. Building on our sovereign data foundation with VAST DataEnclave is expected to let us host those models onshore, inside attested environments where the model owner’s weights and the customer’s data are both protected from everyone, including us.”

James Manning, Co-founder and Chief Executive Officer
7:13 AM ET 8-K
Business Update Ivanhoe Electric Inc. IE

Ivanhoe Electric Business Update

Ivanhoe Electric released an updated S-K 1300 Preliminary Feasibility Study (PFS) for its Santa Cruz Copper Project in Arizona. The report replaces the previous 2025 study and provides updated technical and economic assumptions for the project's development. The company is hosting an investor call and slideshow presentation to discuss the results of the study.

7:11 AM ET 8-K
Business Update Armata Pharmaceuticals, Inc. ARMP

Armata Pharmaceuticals Business Update

Armata Pharmaceuticals received $3.7 million in additional non-dilutive funding from the U.S. Department of War to support the Phase 3 development of its AP-SA02 bacteriophage candidate. This incremental funding brings the total cumulative government support for the program to $32.4 million and is intended to fund activities for a pivotal superiority study in complicated S. aureus bacteremia.

Counterparty
U.S. Department of War
7:02 AM ET 8-K
Financial Results General Mills Inc GIS

General Mills Financial Results

General Mills reported fiscal 2027 first-quarter net sales of $4.4 billion, a 3% decrease primarily due to the divestiture of its U.S. yogurt business. Adjusted diluted EPS fell 13% in constant currency to $0.75, while the company reaffirmed its full-year outlook despite a volatile operating environment.

Term
Q1 2027
Earnings call
Sep 23, 2026, 9:00 AM ET

“We are off to an encouraging start in fiscal 2027, driving improved topline performance with stronger product innovation and renovation focused on the benefits consumers are looking for today.”

Jeff Harmening, General Mills Chairman and Chief Executive Officer

“We are also executing with discipline in a volatile environment, including delivering industry-leading cost savings through our Holistic Margin Management program and our global Transformation initiative. Based on our progress and the actions underway, we remain confident in our ability to deliver our fiscal 2027 guidance.”

Jeff Harmening, General Mills Chairman and Chief Executive Officer
7:00 AM ET Form 4
Insider Buying Agree Realty Corp ADC

Agree Realty Chief Growth Officer Craig Erlich Buys $67.5K of Stock

Craig Erlich, Chief Growth Officer, bought 1,000 shares of Agree Realty Corp at $67.55 a share, worth $67.5K in total on Sep 21, 2026. Shares held after the trade: 60,388 (+1.7%).

Value
$67.5K
Shares
1,000
Price
$67.55
Role
Chief Growth Officer
Holding change
+1.7%
Trade date
Sep 21, 2026
6:40 AM ET 8-K
Leadership Change Angi Inc. ANGI

Angi Leadership Change

Angi Inc. appointed Michael Steib as Chief Executive Officer, succeeding Jeffrey W. Kip who stepped down from the role and the Board effective September 22, 2026. Additionally, Joseph Levin transitioned from Executive Chairman to Chairman of the Board, and the Board size was reduced to nine members.

6:06 AM ET Form 4
Insider Selling Keysight Technologies, Inc. KEYS

Keysight Technologies EVP and CFO Neil Dougherty Sells $682K of Stock

Neil Dougherty, EVP and CFO, sold 2,000 shares of Keysight Technologies, Inc. at $340.79 a share, worth $682K in total on Sep 21, 2026. Shares held after the trade: 123,390 (-1.6%).

Value
$682K
Shares
2,000
Price
$340.79
Role
EVP and CFO
Holding change
-1.6%
Trade date
Sep 21, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.